Zhong Guo Zheng Quan Bao·2025-08-25 20:08Core Insights - The critical viewpoint of the articles highlights the increasing prices of critical illness insurance (CI) and the rising barriers to entry for consumers, leading to a decline in insurance leverage and a shrinking market for CI products [1][2][3] Group 1: Market Trends - The CI insurance market has been experiencing a continuous decline in premium income, which has limited the overall growth of the health insurance sector [3] - By the first half of 2025, the original insurance premium income for health insurance is expected to exceed 620 billion yuan, reflecting a year-on-year growth of 2.3% [3] - Medical insurance is projected to surpass CI insurance in scale by 2024, becoming the leading type of health insurance [3] Group 2: Product Development and Innovation - Insurers are increasingly focusing on medical insurance as a primary product development direction, driven by reforms such as DRG (Diagnosis-Related Group) and DIP (Disease-Related Payment) [4][6] - The industry is moving towards integrating health management services into health insurance products, encouraging consumers to engage in self-health management [6][9] - Innovations in CI insurance are anticipated, with expectations for higher leverage, more specific, and diversified products with shorter terms [6] Group 3: Regulatory and Policy Environment - The financial regulatory authority is working on guidelines to enhance health insurance service levels, aiming to improve industry operational capabilities and adapt supply and demand [9] - Policies are being developed to support the integration of commercial health insurance with innovative drug and medical device payments, which is expected to drive growth in the health insurance sector [7][9] - The introduction of a commercial health insurance innovative drug directory is anticipated to refine product pricing and expand coverage [8]